An open clinical trial of venlafaxine in the treatment of pain, depressive and anxiety symptoms in fibromyalgia

Pain Clinic

Volumn 18, Issue 2, 2006, Pages 167-173

  Evren, Bilge ^a   Evren, Cuneyt ^b,c   Guler, Mine Hosafci ^a  

^a Baltalimani State Hospital for Muskuloskeletal Disorders   (Turkey)

^b Bakirkoy State Hospital for Mental Health and Neurological Disorders   (Turkey)

^c NONE   (Turkey)

Author keywords

Anxiety; Depression; Fibromyalgia; Pain; Selective serotonin noradrenaline reuptake inhibitors; Venlafaxine

Indexed keywords

ANALGESIC AGENT; MUSCLE RELAXANT AGENT; VENLAFAXINE;

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG EFFICACY; FIBROMYALGIA; HUMAN; PAIN; PAIN ASSESSMENT; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 33744915825     PISSN: 01691112     EISSN: None     Source Type: Journal    
DOI: 10.1163/156856906776760416     Document Type: Article

References (27)

1. Wolfe E, Smythe HA, Yunus MB, et al., The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee, Arthritis and Rheumatism 33, 160-72 (1990).
2. Croft P, Schollum J, Silman A, Population study of tender point counts and pain as evidence of fibromyalgia, BMJ 309, 696-9 (1994).
3. Wolfe E, Ross K, Anderson J, et al., The prevalence and characteristics of fibromyalgia in the general population, Arthritis and Rheumatism 38, 19-28 (1995).
4. Ahles TA, Khan SA, Yunus MB, et al., Psychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis, and subjects without pain: a blind comparison of DSM-III diagnoses, Am J Psychiatry 148, 1721-6 (1991).
5. Grothe DR, Scheckner B, Albano D, Treatment of pain syndromes with venlafaxine. Pharmacotherapy 24, 621-9 (2004).
6. Bennett RM, Fibromyalgia: the commonest cause of widespread pain, Compr Ther 21, 269-75 (1995).
7. Arnold LM, Keck PE Jr, Welge JA, Antidepressant treatment of fibromyalgia. A meta-analysis and review, Psychosomatics 41, 104-13 (2000).
8. Miller LJ, Kubes KL, Serotonergic agents in the treatment of fibromyalgia syndrome, Ann Pharmacother 36, 707-12 (2002).
9. O'Malley PG, Balden E, Tomkins G, et al., Treatment of fibromyalgia with antidepressants: a meta-analysis, J Gen Intern Med 15, 659-66 (2000).
10. Arnold LM, Lu Y, Crofford LJ, et al., A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder, Arthritis Rheum 50, 2974-84 (2004).
11. Goldenberg D, Mayskiy M, Mossey C, et al., A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia, Arthritis Rheum 39, 1852-9 (1996).
12. Mochizucki D, Serotonin and noradrenaline reuptake inhibitors in animal models of pain, Hum Psychopharmacol 19 (Suppl. 1), 15-9 (2004).
13. Briley M, Clinical experience with dual action antidepressants in different chronic pain syndromes, Hum Psychopharmacol 19 (Suppl. 1), 21-5 (2004).
14. Dwight MM, Arnold LM, O'Brien H, et al., An open clinical trial of venlafaxine treatment of fibromyalgia, Psychosomatics 39, 14-7 (1998).
15. Sayar K, Aksu G, Ak I, Tosun M, Venlafaxine treatment of fibromyalgia, Ann Pharmacother 37, 1561-5 (2003).
16. Nagaoka S, Ohno M, Sekiguchi A, An open-label clinical trial of milnacipran in fibromyalgia syndrome with co-morbid depressive symptoms, International J Psychiatry in Clinical Practice 8, 47-51 (2004).
17. Vitton O, Gendreau M, Gendreau J, et al., A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia, Hum Psychopharmacol 19 (Suppl. 1), 27-35 (2004).
18. Derogatis LR, SCL-90: Administration, Scoring and Procedure Manual-II for the revised version, Tawson, Clinical Psychometric Research (1983).
19. Dag I, Reability and validity of Symptom Check List-90-Revised among university students, Turkish J Psychiat 2, 5-12 (1991) (in Turkish).
20. Williams BW, A structured interview guide for Hamilton Depression Rating Scale, Arch Gen Psychiatr 45, 742-7 (1978).
21. Akdemir A, Orsel S, Dag I, et al., Reability, validity and clinical use of Hamilton Depression Rating Scale, J Psychiat Psychol Psychopharmacol 4, 251-9 (1996) (in Turkish).
22. Hamilton M, The assessment of anxiety states by rating, Br J Med Psychol 32, 50-5 (1959).
23. Yazici MK, Demir B, Tanriverdi N, et al., Hamilton Anxiety Rating Scale, study of reability and validity among raters, Turkish J Psychiat 9, 114-7 (1998) (in Turkish).
24. Thomas E, Blotman F, Are antidepressants effective in fibromyalgia? Joint Bone Spine 69, 531-3 (2002).
25. Fishbain D, Evidence-based data on pain relief with antidepressants, Ann Med 32, 305-16 (2000).
26. Arnold LM, Hess EV, Hudson JI, et al., A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia, Am J Med 112, 191-7 (2002).
27. Deakin B, Dursun S, Optimizing antidepressant treatment: efficacy and tolerability, Int Clin Psychopharmacol 17 (Suppl. 1), 13-24 (2002).